RN7SL263P
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| RNA, 7SL, cytoplasmic 263, pseudogene | HGNC:HGNC:46279 | 22q11.23 |
GO terms in RN7SL263P
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|
Gene expression in normal tissue: RN7SL263P
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in RN7SL263P
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD126 | Tipifarnib | 3 |
| iGMDRD434 | BMS-536924 | 3 |
| iGMDRD150 | RITA | 3 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD286 | Nsc 632839 | 6 |
| iGMDRD188 | Piperlongumine | 3 |
| iGMDRD61 | Kinetin riboside | 3 |
| iGMDRD60 | Quinoclamine | 3 |
| iGMDRD300 | Tozasertib | 3 |
| iGMDRD505 | Pevonedistat | 3 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in RN7SL263P

